Prescription for danger: A report on the troubling trend of prescription and over-the-counter drug abuse among the nation's teens

2008 ◽  
Keyword(s):  
2016 ◽  
Vol 02 (02) ◽  
Author(s):  
Gustavo Kinrys ◽  
Alexandra K Gold ◽  
Andrew A Nierenberg
Keyword(s):  

1986 ◽  
Vol 7 (8) ◽  
pp. 234-254

Over-the-counter preparations for weight loss have become very popular in this country during the last several years. Most of these preparations are combination stimulants containing phenylpropanolamine, ephedrine, and caffeine. They are widely advertised, readily available, and have become a major item for adolescent drug abuse. All of these substances have potent and direct adrenergic effects and catecholamine-releasing actions. Hypertension, cerebral hemorrhage, and psychosis have all been associated with use of phenylpropanolamine. Caffeine has been reported to cause ventricular arrhythmias, including ventricular tachycardia. There is a possibility that simultaneous ingestion of all of these drugs could increase the risk of toxicity from each. Propanolol is the treatment of choice for toxicity manifested by moderate symptomatic hypertension plus atrial or ventricular arrhythmias.


1976 ◽  
Vol 6 (3) ◽  
pp. 255-258 ◽  
Author(s):  
Charles L. Frederick ◽  
Frank Guldbrandsen

Most concern for drug abuse among drug educators focuses on illicit, youth oriented chemicals such as marijuana and hallucinogens. Even though this is so, we know that a major source of drug abuse stems directly from the prescription pads of medical doctors. Even perfectly justifiable prescriptions for physical and psychical maladies are filled and then used for purposes that damage and destroy human potential. An effort needs to be made in drug education aimed at physicians, working toward dealing with the problem of abuse of over the counter, licit drugs.


1974 ◽  
Vol 4 (3) ◽  
pp. 232-237
Author(s):  
Thomas J. Donegan

Mr. Donegan's presentation touches upon some of the legislative and administrative problems facing the FTC in reviewing unfair practices in drug advertising. The FTC's primary concern is with the truthfulness of advertising practices and is now requiring substantiation of drug claims. Mr. Donegan sees a move in the direction of reviewing the possible relations between drug advertising and drug abuse. He actively encourages empirical research to substantiate this charge.


2017 ◽  
Author(s):  
Daria Suchecka ◽  
Jolanta Kucharska-Mazur ◽  
Katarzyna Groszewska ◽  
Monika Mak ◽  
Jerzy Samochowiec ◽  
...  
Keyword(s):  

2018 ◽  
Vol 48 (8) ◽  
pp. 379-383
Author(s):  
Benjamin T. Li ◽  
Nidal Moukaddam ◽  
Kimberly D. L. Parks ◽  
Asim A. Shah

1976 ◽  
Vol 6 (1) ◽  
pp. 85-90 ◽  
Author(s):  
James D. Cope

When critics raised suggestions that a link existed between drug abuse and the advertising of over-the-counter (OTC) medicines, the Proprietary Association commissioned independent studies to determine if there were truth to the allegations. “The weight of the evidence refutes the alleged relationship between advertising and drug abuse,” concludes the author of this paper. He also outlines the ongoing work of the OTC Review Panels, commissioned by the Food and Drug Administration, to evaluate ingredients in all over-the-counter medicines available to American consumers.


Sign in / Sign up

Export Citation Format

Share Document